0001567619-21-018320.txt : 20211014
0001567619-21-018320.hdr.sgml : 20211014
20211014204019
ACCESSION NUMBER: 0001567619-21-018320
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211014
FILED AS OF DATE: 20211014
DATE AS OF CHANGE: 20211014
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fu Tao
CENTRAL INDEX KEY: 0001644888
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38205
FILM NUMBER: 211324578
MAIL ADDRESS:
STREET 1: 3175 HANOVER STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zai Lab Ltd
CENTRAL INDEX KEY: 0001704292
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4560 JINKE ROAD
STREET 2: BLDG. 1, 4F, PUDONG
CITY: SHANGHAI
STATE: F4
ZIP: 201210
BUSINESS PHONE: 862161632588
MAIL ADDRESS:
STREET 1: 4560 JINKE ROAD
STREET 2: BLDG. 1, 4F, PUDONG
CITY: SHANGHAI
STATE: F4
ZIP: 201210
4
1
doc1.xml
FORM 4
X0306
4
2021-10-14
0
0001704292
Zai Lab Ltd
ZLAB
0001644888
Fu Tao
C/O ZAI LAB LIMITED
4560 JINKE ROAD, BLDG 1, 4TH FLOOR
PUDONG, SHANGHAI
F4
201210
CHINA
1
1
0
0
President & COO
Ordinary Shares
187668
D
Ordinary Shares
2021-10-14
4
S
0
3360
102.02
D
94140
I
See footnote
Ordinary Shares
2021-10-14
4
S
0
5240
102.90
D
88900
I
See footnote
Ordinary Shares
2021-10-14
4
S
0
1400
103.44
D
87500
I
See footnote
The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person's spouse, dated June 17, 2021, expires February 28, 2022 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
Reflects a weighted average sale price of $102.02 per share, at prices ranging from $101.40 to $102.27 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Reflects a weighted average sale price of $102.90 per share, at prices ranging from $102.42 to $103.38 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Reflects a weighted average sale price of $103.44 per share, at prices ranging from $103.43 to $103.50 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Shares held by Reporting Person's spouse.
/s/ Bruce A. Blefeld, Attorney-in-Fact
2021-10-14